Follow
Viola Heinzelmann
Viola Heinzelmann
Professor of Gynecology and Obstetrics, University of Basel
Verified email at usb.ch
Title
Cited by
Cited by
Year
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N Colombo, C Sessa, A Du Bois, J Ledermann, WG McCluggage, ...
Annals of Oncology 30 (5), 672-705, 2019
10732019
Neutrophils escort circulating tumour cells to enable cell cycle progression
BM Szczerba, F Castro-Giner, M Vetter, I Krol, S Gkountela, J Landin, ...
Nature 566 (7745), 553-557, 2019
9692019
Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding
S Gkountela, F Castro-Giner, BM Szczerba, M Vetter, J Landin, R Scherrer, ...
Cell 176 (1), 98-112. e14, 2019
7242019
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer
VA Heinzelmann-Schwarz, M Gardiner-Garden, SM Henshall, J Scurry, ...
Clinical Cancer Research 10 (13), 4427-4436, 2004
2732004
Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines
F Jacob, R Guertler, S Naim, S Nixdorf, A Fedier, NF Hacker, ...
PloS one 8 (3), e59180, 2013
2572013
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
F Jacob, M Meier, R Caduff, D Goldstein, T Pochechueva, N Hacker, ...
Gynecologic oncology 121 (3), 487-491, 2011
2472011
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ...
The Journal of clinical investigation 128 (11), 4912-4923, 2018
2332018
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
C Claus, C Ferrara, W Xu, J Sam, S Lang, F Uhlenbrock, R Albrecht, ...
Science translational medicine 11 (496), eaav5989, 2019
2122019
Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5‐aminolevulinic acid
MK Fehr, R Hornung, A Degen, VA Schwarz, D Fink, U Haller, P Wyss
Lasers in Surgery and Medicine: The Official Journal of the American Society …, 2002
1972002
The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells
A Fedier, RA Steiner, VA Schwarz, L Lenherr, U Haller, D Fink
International journal of oncology 22 (5), 1169-1173, 2003
1712003
Resistance to topoisomerase poisons due to loss of DNA mismatch repair
A Fedier, VA Schwarz, H Walt, RD Carpini, U Haller, D Fink
International journal of cancer 93 (4), 571-576, 2001
1692001
Microtubule-depolymerizing agents used in antibody–drug conjugates induce antitumor immunity by stimulation of dendritic cells
P Müller, K Martin, S Theurich, J Schreiner, S Savic, G Terszowski, ...
Cancer immunology research 2 (8), 741-755, 2014
1632014
Protein significance analysis in selected reaction monitoring (SRM) measurements
CY Chang, P Picotti, R Hüttenhain, V Heinzelmann-Schwarz, M Jovanovic, ...
Molecular & Cellular Proteomics 11 (4), 2012
1592012
The metastatic spread of breast cancer accelerates during sleep
Z Diamantopoulou, F Castro-Giner, FD Schwab, C Foerster, M Saini, ...
Nature 607 (7917), 156-162, 2022
1542022
Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status
M Anugraham, F Jacob, S Nixdorf, AV Everest-Dass, ...
Molecular & Cellular Proteomics 13 (9), 2213-2232, 2014
1532014
Photodynamic therapy of locoregional breast cancer recurrences using a chlorin‐type photosensitizer
P Wyss, V Schwarz, D Dobler‐Girdziunaite, R Hornung, H Walt, A Degen, ...
International journal of cancer 93 (5), 720-724, 2001
1412001
A distinct molecular profile associated with mucinous epithelial ovarian cancer
VA Heinzelmann-Schwarz, M Gardiner-Garden, SM Henshall, JP Scurry, ...
British journal of cancer 94 (6), 904-913, 2006
1382006
Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid
MK Fehr, R Hornung, VA Schwarz, R Simeon, U Haller, P Wyss
Gynecologic oncology 80 (1), 62-66, 2001
1342001
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin
PA Cowin, J George, S Fereday, E Loehrer, P Van Loo, C Cullinane, ...
Cancer research 72 (16), 4060-4073, 2012
1122012
The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells
CE Ford, E Jary, SSQ Ma, S Nixdorf, VA Heinzelmann-Schwarz, RL Ward
PloS one 8 (1), e54362, 2013
1112013
The system can't perform the operation now. Try again later.
Articles 1–20